Physicians' perceived usefulness of and satisfaction with test reports for cystic fibrosis (ΔF508) and factor V Leiden

Genetics in Medicine

Volumn 5, Issue 3, 2003, Pages 166-171

  Krousel Wood, Marie ^a   Andersson, Hans C ^a   Rice, Janet ^a   Jackson, Kelly E ^a   Rosner, Eunice R ^b   Lubin, Ira M ^b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cystic fibrosis; Factor V Leiden; Genetic test; Physician satisfaction; Test result reporting

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5;

ARTICLE; CORRELATION ANALYSIS; CYSTIC FIBROSIS; ETHNIC GROUP; FAMILY; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HEALTH SURVEY; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MUTATION; PHYSICIAN; SATISFACTION; UNITED STATES; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GENETIC SERVICE; GENETICS; HEALTH PERSONNEL ATTITUDE; RANDOMIZED CONTROLLED TRIAL;

ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FACTOR V; GENETIC SERVICES; HUMANS; PHYSICIANS;

EID: 0042806072     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000066797.05220.85     Document Type: Article

References (10)

1. Andersson HC, Krousel-Wood MA, Jackson KE, Rice J, Lubin IM. Medical genetics test reporting for cystic fibrosis and factor V Leiden in North American laboratories. Genet Med 2002;4:324-327.
2. Genetic testing under the Clinical Laboratory Improvement Amendments. Fed Regist 2000;65:87.
3. National Committee for Clinical Laboratory Standards. Molecular Diagnostic Methods for Genetic Diseases. Approved Guidelines. NCCLS Document MM1-A, volume 17. Wayne, PA: National Committee for Clinical Laboratory Standards 2000.
4. The American College of Obstetricians and Gynecologists and American College of Medical Genetics. Preconception and Pranatal Carrier Screening for Cystic Fibrosis, Clinical and Laboratory Guidelines. Washington DC: 2001.
5. Grody WE, Griffin JH, Taylor AK, Korf BR, Heit JA. American of Medical Genetics Consensus statement on factor V Leiden mutation testing. Genet Med 2001;3:139-148.
6. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-154.
7. McGovern MM, Benach MO, Wallenstein S, Desnick RJ, Keenlyside R. Quality assurance in molecular genetic testing laboratories. JAMA 1998;281:845-847.
8. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336:823-827.
9. Sandhaus LM, Singer ME, Dawson NV, Wiesner GL. Reporting BRCA test results to primary care physicians. Genet Med 2001;3:327-334.
10. Menasha JD, Schechter C, Willner J. Genetic testing: A physician's perspective. Mt Sinai J Med 2000;67:144-151.